Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
SOURCE Research and Markets
DUBLIN, October 3, 2017 /PRNewswire/ --
The "Global Tumor Ablation Market Forecast & Regional Analysis 2023" report has been added to Research and Markets' offering.
The overall market opportunity for Tumor ablation therapy is expected to surpass US$ 1.2 Billion by 2023.
The tumor ablation therapy segment has shown impressive improvements since it was first accepted as a therapeutic with current tumor ablation being more advanced and accurate, further causing much lesser trauma to patient. It also shows faster recovery and lesser time than the other existing invasive procedures. The tumor ablation therapy is widely being accepted as a minimally invasive cancer therapeutic, which has thus led to the formation of a whole new market based on tumor ablation with global research and development contributing immensely in the growth and expansion of the market. Further, innovation in the resources and technology required in the tumor ablation has opened up ample opportunities for various pharmaceutical and electronics company to work for the betterment of the currently available technology for tumor ablation.
Over the years, tumor ablation therapy market has shown immense improvements in all of its segments. Our analysis clearly indicates that tumor ablation technology and devices market is currently the most profitable market leading all other ablation segments with major contribution from the radiofrequency ablation technology. The early and timely introduction of radiofrequency ablation technology, when an effective alternative for tumor surgery was required has been the prime reason for its dominance in the tumor ablation therapy market.
The high success rate of tumor ablation has been one of the promoting factors of the novel therapeutic, thus making it one of the most preferable tumor therapies where other therapeutics might not be feasible for multiple reasons. The tumor ablation technique has been used for the treatment of various types of cancer such as liver cancer, lung cancer, prostate cancer, colorectal cancer etc.
The ongoing technical innovations have made tumor ablation procedure safe and painless with impressive results during and after treatment. With rising awareness in the healthcare industry all over the world, cancer ablation is steadily getting popular as one of the most preferred method of cancer therapy for various types of cancer. Hospitals and healthcare centers realize the immense potential that cancer ablation therapy has, thus providing the facility to their patients which would further help in promoting the therapeutic.
Key Topics Covered:
1. Tumor Ablation - A Minimally Invasive Cancer Therapeutic
1.1 Prologue to Tumor Ablation Therapy
1.2 History & Progress of Tumor Ablation Therapy
2. Demand & Features of the Tumor Ablation Therapy
2.1 Dire Need for a Safe & Non-Invasive Cancer Therapy
2.2 Compelling Features of the Tumor Ablation Therapy
3. Tumor Ablation - Providing an Edge over Existing Cancer Therapeutics
3.1 Direct Tumoricidal Effect
3.2 Minimal Invasive Therapy
3.4 Applicable to a Non-surgical Candidate
3.5 Swift Procedure With Faster Recovery
3.6 Can be Repeated Multiple Times
4. Technological Aspect of Tumor Ablation Therapy
5. Radiofrequency Ablation Therapy
5.2 Therapeutic Mechanism of Radiofrequency Ablation
6. Microwave Tumor Ablation Therapy
6.1 The Physics of Microwave & its Therapeutic Mechanism
6.2 Superiority of Microwave Ablation Therapy Compared to Radiofrequency Ablation Therapy
7. Cryoablation Therapy
7.1 Cryoablation Therapy - An Emerging Modern Cancer Ablation Procedure
7.2 Procedure, Mechanism & Clinical Applications of Cryoablation Therapy
8. High Intensity Focused Ultrasound (HIFU)
8.1 An Insight into the Progress of HIFU over the Last Decade
8.2 Working Mechanism of High Intensity Focused Ultrasound
9. Other Tumor Ablation Therapeutics
9.1 Laser Induced Thermal Therapy for Tumor Ablation
9.2 Irreversible Electroporation Ablation (IER)
10. Tumor Ablation Types by Mode of Treatment
10.1 Surgical Ablation of Tumors
10.2 Laparoscopic Tumor Ablation
10.3 Percutaneous Tumor Ablation
11. Technology, Devices & Tools Involved in Tumor Ablation Therapy
11.1 Imaging Technologies
11.1.1 Computed Tomography
11.1.2 Magnetic Resonance Imaging (MRI)
11.2 Catheters or Probes
12. Clinical Status of Tumor Ablation Therapy in Various Cancer Types
12.1 Primary Hepatocellular Carcinoma (HCC)
12.2 Non-Small Cell Lung Cancer
12.3 Renal (Kidney Tumor Ablation)
12.4 Prostate Cancer
12.5 Breast Cancer
12.6 Bone Metastasis
13. Recent Advances in Tumor Ablation Therapy
14. Exploring the Commercial Aspects of Tumor Ablation Therapy
14.1 Cost Benefit Analysis of Tumor Ablation Therapy
14.2 Tumor Ablation Cost Analysis
14.2.1 Common Cost of Tumor Lesion Treatment Using any of the Available Ablation Modalities
14.2.2 Modality Specific Ablation Cost for a 3cm Kidney Lesion
15. Global Tumor Ablation Therapy Market Current Scenario
15.1 Tumor Ablation Market by Technology
15.2 Tumor Ablation Therapy Market by Mode of Treatment
15.3 Tumor Ablation Market by Application
16. Tumor Ablation Therapy Market by Region
16.1 North America
16.3 Asia Pacific
16.4 Rest of the World
17. Global Tumor Ablation Therapy Market Dynamics
17.1 Driving Factors of the Tumor Ablation Market
17.2 Restraining Factors in the Growth of Tumor Ablation Therapy Market
18. Anticipation Regarding the Future of Tumor Ablation Therapy Market
19. Competitive Landscape
19.2 Boston Scientific
19.3 Galil Medicals
19.4 INTIO Inc.
19.5 Medtronic Inc.
19.6 Misonix Inc.
19.7 NeuWave Medical Inc.
19.8 SonaCare Medical
19.10 BSD Medicals
19.12 Halyard Health
For more information about this report visit https://www.researchandmarkets.com/research/nlhc6w/global_tumor
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-tumor-ablation-market-2023-300529786.html
©2017 PR Newswire. All Rights Reserved.